Elite Pharmaceuticals Inc (ELTP)
0.5101
+0.01
(+1.75%)
USD |
OTCM |
Nov 04, 16:00
Elite Pharmaceuticals Profit Margin (Quarterly): 3.27% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.27% |
| March 31, 2024 | 18.53% |
| December 31, 2023 | 4.55% |
| September 30, 2023 | |
| June 30, 2023 | 12.71% |
| March 31, 2023 | -14.22% |
| December 31, 2022 | 32.11% |
| September 30, 2022 | 17.65% |
| June 30, 2022 | 3.99% |
| March 31, 2022 | 31.66% |
| December 31, 2021 | 25.44% |
| September 30, 2021 | 21.00% |
| June 30, 2021 | 33.86% |
| March 31, 2021 | -10.98% |
| December 31, 2020 | 33.28% |
| September 30, 2020 | 33.54% |
| June 30, 2020 | 14.29% |
| March 31, 2020 | 18.93% |
| December 31, 2019 | -36.81% |
| September 30, 2019 | -34.43% |
| June 30, 2019 | 8.33% |
| March 31, 2019 | -198.2% |
| December 31, 2018 | -87.02% |
| September 30, 2018 | -189.5% |
| June 30, 2018 | -77.86% |
| Date | Value |
|---|---|
| March 31, 2018 | -177.2% |
| December 31, 2017 | -19.33% |
| September 30, 2017 | |
| June 30, 2017 | -127.4% |
| March 31, 2017 | -236.3% |
| December 31, 2016 | 71.51% |
| September 30, 2016 | |
| June 30, 2016 | 33.44% |
| March 31, 2016 | |
| December 31, 2015 | -557.6% |
| September 30, 2015 | -57.06% |
| June 30, 2015 | |
| March 31, 2015 | -514.6% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | -180.2% |
| March 31, 2014 | -3.06K% |
| December 31, 2013 | -62.71% |
| September 30, 2013 | -831.6% |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | -1.82K% |
| March 31, 2012 | -1.08K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-36.81%
Minimum
Dec 2019
33.86%
Maximum
Jun 2021
13.49%
Average
18.09%
Median
Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 14.22% |
| BioCardia Inc | -54.87K% |
| Zevra Therapeutics Inc | -447.9% |
| Verrica Pharmaceuticals Inc | -332.0% |
| Terns Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 41.23% |
| Return on Assets | 26.94% |
| Return on Invested Capital | 35.50% |
| Gross Profit Margin (Quarterly) | 45.07% |
| Operating Margin (Quarterly) | 20.55% |
| Return on Net Operating Assets | 36.05% |